The latest report by IMARC Group, titled “Digital Dose Inhaler Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global digital dose inhaler market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2028, exhibiting a growth rate (CAGR) of 14.6% during 2023-2028.
Patients with asthma and chronic obstructive pulmonary disease (COPD) use digital dosage inhalers. They contain sensors that provide a low-dose warning indicator and track when medications are administered. In addition, they feature sizable display panels that are simple for a variety of sufferers to view and comprehend. They are gaining tremendous popularity all around the world since they are combined with cutting-edge technology to facilitate the automatic transfer of data.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/digital-dose-inhaler-market/requestsample
Digital Dose Inhaler Market Trends and Drivers:
Chronic respiratory diseases (CRDs), including bronchial asthma, lung problems, and pulmonary hypertension (PH), are becoming more common. This increase in incidence can be attributed to increased levels of pollution and dust exposure from occupational sources. This is one of the main elements that has a favorable bearing on the demand for digital dosage inhalers globally. In addition, non-governmental organizations (NGOs) and national governing bodies are educating people about CRDs and their treatments. This is accelerating market expansion. The launch of disposable dry powder inhaler (DPI) devices that are capsule-based is driving the industry even further.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Branded Medication
- Generics Medication
Breakup by Product:
- Metered Dose Inhaler
- Dry Powder Inhaler
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- 3M Company
- AstraZeneca plc
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Limited
- H&T Presspart Manufacturing Ltd.
- Koninklijke Philips N.V.
- Lupin Limited
- Novartis AG
- OPKO Health Inc.
- Propeller Health (ResMed)
- Sensirion AG Switzerland
- Teva Pharmaceutical Industries Ltd.
Explore full report with table of contents: https://www.imarcgroup.com/digital-dose-inhaler-market
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
